Human papillomavirus status and cervical abnormalities in women from public and private health care in Rio de Janeiro State, Brazil

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 48, Issue 5, 2006, Pages 279-285

  Oliveira, Ledy H S ^a   Rosa, Maria L G ^a   Pereira, Claudia R N ^a   Vasconcelos, Gentil A L B M ^a   Silva, Roberta A ^a   Barrese, Tomás Z ^a   Carvalho, Maria O O ^a   Abib Abi, Gabriela M ^a   Rodrigues, Eliana M ^a   Cavalcanti, Silvia M B ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Cervical intraepithelial neoplasias; Human papillomavirus; Hybrid capture; PCR; Socioeconomic factors

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; BRAZIL; CONTROLLED STUDY; DNA DETERMINATION; DNA FINGERPRINTING; FEMALE; GENOTYPE; HEALTH CARE SYSTEM; HIGH RISK POPULATION; HUMAN; INFECTION RISK; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIVATE HOSPITAL; PUBLIC HEALTH SERVICE; RISK ASSESSMENT; SOCIOECONOMICS; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; VIRUS IDENTIFICATION; VIRUS INFECTION; WART VIRUS;

EID: 33750731971     PISSN: 00364665     EISSN: 16789946     Source Type: Journal    
DOI: 10.1590/s0036-46652006000500008     Document Type: Article

References (43)

1. ADIMORA, A.A.; HOLLI, H.A.; KING, H.K. & SPARLING, P.F. - Sexually transmitted disease. In Epidemiology of sexually transmitted disease 2. ed. New York, McGraw-Hill International Editions, 1994. p. 1-9.
2. ANTONSSON, A.; ERFURT, C.; HAZARD, K. et al. - Prevalence and type spectrum of human papillomaviruses in healthy skin samples collected in three continents. J. gen. Virol., 84: 1881-1886, 2003.
3. BOSCH, F.X.; MANOS, M.M.; MUNOZ, N. et al. - Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J. nat. Cancer Inst., 87: 796-802, 1995.
4. BOZZETTI, M.; NONNENMACHER, B.; MIELZINSKA, I.I. et al. - Comparison between hybrid capture II and polymerase chain reaction results among women at low risk for cervical cancer. Ann. Epidem., 10: 466, 2000.
5. BRASIL. MINISTÉRIO DA SAUDE, INSTITUTO NACIONAL DO CÂNCER - Programa Nacional do controle de câncer do colo de útero e de mama, 2003. http://www.inca.gov.br/
6. BRASIL. MINISTÉRIO DA SAUDE, INSTITUTO NACIONAL DO CÂNCER - Estimativa de incidência e mortalidade por câncer no Brasil, 2003. http://www.inca.org.br
7. BRASIL. MINISTÉRIO DA SAÚDE, INSTITUTO NACIONAL DO CÂNCER - Estimativa de incidência e mortalidade por câncer no Brasil, 2005. http://www.inca.org.br
8. BRUCK, L.R.; ZEE, S.; POULOS, B.; CARROLL, D. & ABADI, M. - Detection of cervical human papillomavirus infection by in situ hybridization in fetuses from women with squamous intraepithelial lesions. J. low. genit. Tract Dis., 9: 114-117, 2005.
9. CÂMARA, G.N.L.; CERQUEIRA, D.M.; OLIVEIRA, A.P.G. et al. - Prevalence of human papillomavirus types in women with pre-neoplastic and neoplastic cervical lesions in the Federal District of Brazil. Mem. Inst. Oswaldo Cruz, 98: 879-883, 2003.
10. CARVALHO, M.O.O.; ALMEIDA, R.W.; LEITE, F.M.S. et al. - Detection of human papillomavirus DNA by the hybrid capture assay. Braz. J. infect. Dis., 7: 121-125, 2003.
11. DALSTEIN, V.; RIETHMULLER, D.; PRETET, J.L. et al. - Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int. J. Cancer, 106: 396-403, 2003.
12. DIGENE CORPORATION PRESS RELEASE - Digene high-risk HPV DNA test approved by the FDA for adjunctive screening in women age 30 and older. Gaithersburg, Md, USA, 2003.. Available at: http: //www.digene.com/corporate01/press_releases/ prelease_frame.html.
13. EVANDER, M.; EDLUND, K.; GUSTAFSSON, A. et al. - Human papillomavirus infection is transient in young women: a population-based cohort study. J. infect. Dis., 171: 1026-1030, 1995.
14. FRANCO, E.L. - Primary screening of cervical cancer with human papillomavirus test. J. nat. Cancer Inst. Monogr., 31: 89-96, 2003.
15. FRANCO, E.L.; VILLA, L.L.; SOBRINHO, J.P. et al. - Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J. infect. Dis., 180: 1415-1423, 1999.
16. FUJII, T.; MASUMOTO, N.; SAITO, M. et al. - Comparison between in situ hybridization and real-time PCR technique as a means of detecting the integrated form of human papillomavirus 16 in cervical neoplasia. Diagn. Molec. Path., 14: 103-108, 2005.
17. GALL, K.; PAVICIC, D.; PAVELIC, J.; AUDY-JURKOVIC, S. & PAVELIC, K. - PCR amplification of DNA from stained cytological smears. J. clin. Path., 46: 378-379, 1993.
18. IFTNER, T. & VILLA, L.L. - Human papillomavirus technology. J. nat. Cancer Inst. Monogr., 31: 80-88, 2003.
19. KJAER, S.K.; SVARE, E.I.; WORM, A.M. et al. - Human papillomavirus infection in Danish female sex workers. Decreasing prevalence with age despite continuously high sexual activity. Sex. transm. Dis., 27: 438-445, 2000.
20. KJAER, S.K.; VAN DEN BRULE, A.J.C.; PAULL, G. et al. - Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow-up study. Brit. med. J., 325: 572-576, 2002.
21. LAWSON, H.W.; LEE, N.C.; THAMES, S.F.; HENSON, R. & MILLER, D.S. - Cervical cancer screening among low-income women: results of a national screening program, 1991-1995. Obstet. Gynecol., 92: 745-752, 1998.
22. LEFEVRE, J; HANKINS, C; MONEY, D; RACHLIS, A. et al. - Human papillomavirus type 16 viral load is higher in human immunodeficiency virus-seropositive women with high-grade squamous intraepithelial lesions than in those with normal cytology smears. J. clin. Microbiol., 42: 2212-2215, 2004.
23. MANOS, M.M.; TING, Y.; WRIGHT, D.K. et al. - - Use of polymerase chain reaction amplification for detection of genital papillomavirus. Cancer Cells, 29: 20-27, 1989.
24. MAO, C.; BALASUBRAMANIAN, A. & KOUTSKY, L.A. - Should liquid-based cytology be repeated at the time of colposcopy? J. low. genit. Tract. Dis., 9 : 82-88, 2005.
25. MOSCICKI, A.B.; SHIBOSKI, S.; BROERING, J. et al. - The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J. Pediat., 132: 277-284, 1998.
26. MOSCICKI, A.B.; SHIBOSKI, S.; HILLS, N.K. et al. - Regression of low-grade squamous intra-epithelial lesions in young women. Lancet, 364: 1678-1683, 2004.
27. MUÑOZ, N. - Human papillomavirus and cancer: the epidemiological evidence. J. clin. Virol, 19: 1-5, 2000.
28. MUÑOZ, N.; BOSCH, F.X.; SANJOSÉ, S. et al. - Epidemiologic classification of human papillomavirus types associated with cervical cancer. New Engl. J. Med., 348: 518-527, 2003.
29. NONOGAKI, S.; WAKAMATSU, A.; LONGATTO FILHO, A. et al. - Hybrid capture II and polymerase chain reaction for identifying HPV infections in samples collected in a new collection medium: a comparison. Acta cytol. (Philad.), 48: 514-520, 2004.
30. NORONHA, V.; MELLO, W.; VILLA, L. et al. - Papilomavírus humanos associados a lesões de cérvice uterina. Rev. Soc. bras. Med. trop., 32: 235-240, 1999.
31. OLIVEIRA, L.H.S.; RODRIGUES, E.V.; LOPES, A.P.S.; FERNANDEZ, A.P. & CAVALCANTI, S.M. - HPV 16 detection in cervical lesions, physical state of viral DNA and changes in p53 gene. São Paulo med. J., 121: 67-71, 2003.
32. PARIKH, S.; BRENNAN, P. & BOFFETTA, P. - Meta-analysis of social inequality and the risk of cervical cancer. Int. J. Cancer, 105: 687-681, 2003.
33. PEYTON, C.L.; GRAVITT, P.E.; HUNT, W.C. et al. - Determinants of genital human papillomavirus detection in a US population. J. infect. Dis., 183: 1554-1564, 2001.
34. PEYTON, C.L.; SCHIFFMAN, M.; LORINCZ, A.T. et al. - Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J. clin. Microbiol., 36: 3248-3254, 1998.
35. RABELO-SANTOS, S.H.; ZEFERINO, L.; VILLA, L.L. et al. - Human papillomavirus prevalence among women with cervical intraepithelial neoplasia III and invasive cervical cancer from Goiania, Brazil. Mem. Inst. Oswaldo Cruz, 98: 181-184, 2003.
36. REID, R.; GREENBERG, M.; JENSON, A.B. et al. - Sexually transmitted papillomavirus infection. I. The anatomic distribution and pathologic grade of neoplastic lesions associated with different viral types. Amer. J. Obstet. Gynec., 156: 212-222, 1987.
37. ROTELI-MARTINS, C.M.; PANETTA, K.; ALVES, V.A. et al. - Cigarette smoking and high-risk HPV DNA as predisposing factors for high-grade cervical intraepithelial neoplasia (CIN) in young Brazilian women. Acta obstet. gynec. scand., 77: 678-682, 1998.
38. SCHADENDORF, D.; TIEDEMANN, K.H.; HAAS, N. & CZARNETZKI, B.M. -Detection of human papillomaviruses in paraffin-embedded condylomata acuminata - comparison of immunohistochemistry, in situ hybridization, and polymerase chain reaction. J. invest. Derm., 97: 549-554, 1991.
39. SCHIFFMAN, M. & CASTLE, E. - Human papillomavirus: epidemiology and public health. Arch. Path. Lab. Med., 127: 930-934, 2003.
40. SCHIFFMAN, M. & KJAER, S.K. - Natural history of anogenital human papillomavirus infection and neoplasia. J. nat. Cancer Inst. Monogr., 31: 14-19, 2003.
41. VERNON, S.D.; UNGER, E.R. & WILLIAMS, D. - Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. J. clin. Microbiol., 38: 651-655, 2000.
42. WRIGHT Jr., T.C.; SCHIFFMAN, M.; SOLOMON, D. et al. - Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet. Gynec., 103: 304-309, 2004.
43. WU, Y.; CHEN, Y.; LI, L. et al. - Associations of high-risk HPV types and viral load with cervical cancer in China. J. clin. Virol., 35: 264-269, 2006.